MOTS-C is a mitochondria-derived peptide that plays a key role in regulating metabolic homeostasis and energy balance at the cellular level. Preclinical research indicates that MOTSC can influence insulin sensitivity, glucose metabolism, and lipid utilization, supporting overall metabolic health. It may also promote mitochondrial efficiency, cellular resilience, and adaptive stress responses, making it of interest in longevity, performance, and metabolic optimization protocols.

Clinicians may integrate MOTSC into comprehensive programs targeting weight management, metabolic function, and age-related decline. Its mechanism of action supports a multi-system approach to health, complementing lifestyle and nutritional interventions. As with all peptide therapies, MOTSC use should be guided by physician evaluation, individualized dosing strategies, and adherence to regulatory standards